The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia. by Tadesse, Fitsum G et al.
Tadesse, FG; van den Hoogen, L; Lanke, K; Schildkraut, J; Tetteh, K;
Aseffa, A; Mamo, H; Sauerwein, R; Felger, I; Drakeley, C; Gadissa,
E; Bousema, T (2017) The shape of the iceberg: quantification of
submicroscopic Plasmodium falciparum and Plasmodium vivax para-
sitaemia and gametocytaemia in five low endemic settings in Ethiopia.
Malar J, 16 (1). p. 99. ISSN 1475-2875 DOI: 10.1186/s12936-017-
1749-4
Downloaded from: http://researchonline.lshtm.ac.uk/3582122/
DOI: 10.1186/s12936-017-1749-4
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Tadesse et al. Malar J  (2017) 16:99 
DOI 10.1186/s12936-017-1749-4
RESEARCH
The shape of the iceberg: quantification 
of submicroscopic Plasmodium falciparum 
and Plasmodium vivax parasitaemia 
and gametocytaemia in five low endemic 
settings in Ethiopia
Fitsum G. Tadesse1,2,3 , Lotus van den Hoogen4, Kjerstin Lanke1, Jodie Schildkraut1, Kevin Tetteh4, 
Abraham Aseffa3, Hassen Mamo5, Robert Sauerwein1, Ingrid Felger6,7, Chris Drakeley4, Endalamaw Gadissa3 
and Teun Bousema1,4*
Abstract 
Background: The widespread presence of low-density asymptomatic infections with concurrent gametocytes may 
be a stumbling block for malaria elimination. This study investigated the asymptomatic reservoir of Plasmodium falci-
parum and Plasmodium vivax infections in schoolchildren from five settings in northwest Ethiopia.
Methods: Two cross-sectional surveys were conducted in June and November 2015, enrolling 551 students from 
five schools and 294 students from three schools, respectively. Finger prick whole blood and plasma samples were 
collected. The prevalence and density of P. falciparum and P. vivax parasitaemia and gametocytaemia were determined 
by 18S rRNA quantitative PCR (qPCR) and pfs25 and pvs25 reverse transcriptase qPCR. Antibodies against blood stage 
antigens apical membrane antigen-1 (AMA-1) and merozoite surface protein-1 (MSP-119) were measured for both 
species.
Results: Whilst only 6 infections were detected by microscopy in 881 slides (0.7%), 107 of 845 blood samples (12.7%) 
were parasite positive by (DNA-based) qPCR. qPCR parasite prevalence between sites and surveys ranged from 3.8 to 
19.0% for P. falciparum and 0.0 to 9.0% for P. vivax. The median density of P. falciparum infections (n = 85) was 24.4 par-
asites/µL (IQR 18.0–34.0) and the median density of P. vivax infections (n = 28) was 16.4 parasites/µL (IQR 8.8–55.1). 
Gametocyte densities by (mRNA-based) qRT-PCR were strongly associated with total parasite densities for both P. 
falciparum (correlation coefficient = 0.83, p = 0.010) and P. vivax (correlation coefficient = 0.58, p = 0.010). Antibody 
titers against P. falciparum AMA-1 and MSP-119 were higher in individuals who were P. falciparum parasite positive in 
both surveys (p < 0.001 for both comparisons).
Discussion: This study adds to the available evidence on the wide-scale presence of submicroscopic parasitaemia by 
quantifying submicroscopic parasite densities and concurrent gametocyte densities. There was considerable hetero-
geneity in the occurrence of P. falciparum and P. vivax infections and serological markers of parasite exposure between 
the examined low endemic settings in Ethiopia.
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Background
The remarkable success that was documented in the con-
trol of malaria in the last decade and half has intensi-
fied efforts to achieve malaria elimination and brought 
eradication back on the table [1]. Detailed assessments of 
parasite carriage by conventional diagnostics alongside 
molecular investigation have uncovered a considerable 
proportion of malaria infections is undetected by micros-
copy and rapid diagnostic tests (RDT) [2, 3]. In settings 
where recent malaria control efforts have been successful, 
submicroscopic infections frequently outnumber micro-
scopically detectable infections [3–5]. Whilst the clinical 
consequences of apparently asymptomatic submicroscopic 
infections are unknown [6, 7], infections may last for sev-
eral months [8] and are associated with gametocyte pro-
duction [9–11]. Gametocytes are essential for onward 
malaria transmission to mosquitoes. Although non-lin-
ear, the likelihood of mosquito infections increases with 
increasing gametocyte density [12] and microscopically 
detectable gametocytes are thus more likely to result in 
mosquito infections than submicroscopic gametocyte den-
sities [4, 13]. Submicroscopic infections may nevertheless 
contribute considerably to malaria transmission because of 
their relative abundance in populations [10, 14].
Ethiopia has experienced a 66% decline in confirmed 
malaria cases between 2001 and 2011 [15]. Motivated 
by this decline, mainly attributed to wide-scale deploy-
ment of long-lasting insecticide-treated nets and imple-
mentation of artemisinin-based combination therapy 
(ACT) [15], the country set a plan to eliminate malaria 
in selected low-transmission settings by the end of 2020 
[16]. Microscopy and RDT may be insufficiently sensitive 
to guide or evaluate these elimination efforts. Molecular 
assays to sensitively detect Plasmodium falciparum and 
Plasmodium vivax infections and serological assays of 
malaria exposure may be of great value in low-endemic 
settings [17, 18].
Previous studies in Ethiopia reported a high degree of 
submicroscopic parasite carriage [19–24] and underlined 
the relevance of (school) surveys using serological mark-
ers of malaria exposure to determine spatial and tempo-
ral variations [25]. However, none of these studies used 
serological and molecular assays together or quantified 
the low-density infections or circulating gametocytes. A 
better understanding of the distribution and contribu-
tion of submicroscopic infections to the overall parasite 
reservoir in low-endemic settings is a prerequisite for 
elimination efforts in order to shape the measures to be 
taken. The present study evaluated spatial and temporal 
variation in submicroscopic parasite and gametocyte car-
riage along with serological markers of malaria exposure 
in asymptomatic schoolchildren at five different sites in 
northwest Ethiopia.
Methods
Ethics statement
The study was reviewed and approved by the Institutional 
Ethics Review Board of the College of Natural Sciences at 
Addis Ababa University (ref. CNSDO/1/07/14), AHRI/
ALERT Ethical Review Committee (ref. PO52/14) at 
Armauer Hansen Research Institute (AHRI), the Obser-
vational/Interventions Research Ethics Committee (ref. 
8626) at London School of Hygiene and Tropical Medi-
cine (LSHTM) and the National Research Ethics Review 
Committee (3.10|016\20) at the Ministry of Science and 
Technology of the Federal Democratic Republic of Ethio-
pia. Community sensitization was conducted using a cas-
cade approach [26]. All parents of children who met the 
basic recruitment criteria were informed about the study 
and offered the choice to participate through an oral 
informed consent process. Written consent for the study 
was provided by a committee that comprised the school 
principal, deputy principal, classroom leaders, woreda 
(district) officials, elders, religious leaders and repre-
sentatives of the family school association while parents 
maintained the right to withdraw their child from the 
survey.
Study area and population
The study was conducted in five elementary schools 
located in the kebeles of Andassa (1730masl, N 
11°30′14.5″ and E°37°29′07.9″); Yinessa (1853masl, N 
11°31′42.0″ and E°37°18′26.7″), Ahuri (2010masl, N 
11°24′00.7″ and E°36°56′53.0″); Yeboden (1997masl, N 
11°18′50.8″ and E°36°57′49.3″) and Fendika (1218masl, N 
11°34′00.3″ and E °36°29′22.9″) in the Amhara Regional 
State of Ethiopia (Fig. 1). Andassa and Yinessa are located 
in Bahir Dar Zuria woreda; Ahuri and Yeboden in Debub 
Achefer woreda and Fendika is the administrative town 
of Jawi woreda. Two seasonal peaks of malaria transmis-
sion occur in the study areas; the main peak follows the 
heaviest rainfall that lasts from June to September, with 
a smaller peak in transmission in April/May following 
the short rains. The study sites, except Jawi, are located 
in the highlands of the North-Western part of Ethiopia, 
around the Lake Tana and Blue Nile river basin. Most of 
the study sites are characterized by swampy areas or irri-
gation lines that are associated with small water bodies 
conducive for anopheline breeding.
Two cross-sectional surveys were undertaken in June 
and November 2015, representing the beginning of the 
rainy season and the peak malaria transmission season, 
respectively. However, due to the recent El Ǹino phe-
nomenon that occurred during the study period the 
rain was intermittent and most of the areas were dry. 
Study participants were selected randomly among stu-
dents attending the elementary schools stratified by age 
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following protocols developed by Brooker et al. [26]. One 
hundred and ten students were targeted for each school 
from five class levels (2–6); 22 students from each class 
comprising 11 boys and 11 girls. The same students were 
invited for both surveys.
Sample collection and microscopic parasite detection
Detailed clinical and demographic data and utilization 
of intervention services was recorded with a pre-tested 
semi-structured interview based questionnaire. Axillary 
body temperature was first checked for all students. If the 
student was found febrile (axillary temperature ≥37.5 °C) 
or reported a history of fever in the past 48  h, an RDT 
(First Response Malaria Ag (pLDH/HRP2) Combo RDT, 
Premier Medical Corporation Ltd., India) was immedi-
ately used to diagnose the presence of malaria parasites. 
If the child was not febrile, a finger-prick sample (0.3–
0.4 mL blood) was collected for microscopy examination 
of infection with thick and thin blood smears, dried blood 
spots (DBS) on 3MM Whatman filter paper (Whatman, 
Maidstone, UK) and in an EDTA-coated microtainer 
tube (BD). EDTA blood samples were centrifuged imme-
diately using portable centrifuge powered from a car 
battery for 3 min (at 3000 rpm) and the plasma was put 
into an equal volume of 0.05% sodium azide (SIGMA-
ALDRICH) solution. The cell pellet was put into RNAp-
rotect buffer (QIAGEN) in a 1:5 ratio and was used for 
extraction of nucleic acids to determine parasite density 
by qPCR and RNA-based gametocyte detection. DBS was 
stored in self-indicating silica gel desiccant beads (Gee-
jay Chemicals Ltd). Plasma, cell pellet and DBS samples 
were shipped on ice packs from the field to the Amhara 
Regional Laboratory in Bahir Dar. There, samples were 
stored at −20 °C, before being shipped in liquid nitrogen 
containers to Addis Ababa and from there shipped on 
dry-ice to laboratories in London and Nijmegen where 
they were stored at −80 °C until further investigation.
Blood smears were stained at the sites for 10 min with 
10% Giemsa (VWR) and then screened for malaria asex-
ual parasites and gametocyte stages. Slides were declared 
Fig. 1 Map of study districts. The study was conducted in two surveys in the northwestern part of Ethiopia around the Lake Tana and Blue Nile river 
basin. Children from five elementary schools (Andassa, Yinessa, Ahuri, Yeboden and Jawi) were studied in the first survey in June 2015. During the 
second survey, in November 2015, students from three of the same schools (Andassa, Ahuri, Jawi) were studied
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negative if no parasites were observed in 100 microscopic 
fields. Asexual parasites and gametocytes were counted 
against 200 and 500 white blood cells, respectively. Slides 
were read independently by two microscopists in the field 
and at AHRI’s facility. A third, WHO certified, profes-
sional microscopist read the slides to verify the disagree-
ment in the reading results from the two readers.
Nucleic acid extraction, parasite and gametocyte detection 
by qPCR and qRT‑PCR
Total nucleic acids were extracted from 600 μL aliquots 
containing 100  μL cell pellet plus 500  μL RNAprotect 
buffer (QIAGEN) using a MagNAPure LC automatic 
extractor and total Nucleic Acid Isolation Kit—High Per-
formance (Roche Applied Science) and eluted in 50  μL 
elution buffer. qPCR for parasite detection was per-
formed by targeting the 18S rRNA small subunit gene 
on DNA for P. falciparum and P. vivax using primer and 
probe sequences described in Hermsen et  al. [27] and 
Wampfler et  al. [28], respectively. Genomic human and 
parasite DNA was digested with the RQ1 DNaseI Digest 
Kit (Promega), then cDNA was synthesized with the High 
Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems) for evaluation of transcription level of Pfs25 and 
Pvs25 to quantify P. falciparum and P. vivax gametocytes, 
respectively. Parasite and gametocyte quantification was 
done based on models developed by Wampfler et al. [28] 
and Koepfli et  al. [11]. Briefly, plasmid constructs from 
Wampfler et al. [28], except the P. falciparum 18S rRNA 
target on DNA, were used to infer copy numbers, then 
the model was applied to calculate the corresponding 
parasite and gametocyte counts for P. falciparum and P. 
vivax parasitaemia and P. falciparum gametocytaemia 
[28] and for the P. vivax gametocytaemia [11]. The P. 
falciparum 18S rRNA gene was cloned into TOPO®-TA 
Cloning vector (Thermo Fisher Scientific) following 
the company’s protocol. Serial dilutions (106, 105 and 
104) of plasmids containing the respective amplicons 
in triplicates were run in parallel on every plate to gen-
erate standard curves for quantification of copy num-
bers. Ten percent of positive samples were retested as 
quality control. All cDNA samples that passed through 
DNA digestion were further checked for genomic DNA 
contamination.
The Pfs25 sequence was amplified using GoTaq® qPCR 
Master Mix (Promega) that contains a proprietary dye 
and the rest (the Pvs25 and the P. falciparum and P. 
vivax 18S rRNA targets on DNA) were amplified using 
probe based detection using TaqMan Fast Advanced 
Master Mix (Applied Biosystems). Melt curves were 
run to evaluate detection of the specific product when 
the detection was not probe based. In all assays, both 
qPCR and qRT-PCR, 104 nM probe and 833 nM primer 
concentrations were used. All probes were from Life 
technologies (Applied Biosystems), primers were from 
SIGMA ALDRICH, and CFX96™ Real-Time PCR Detec-
tion System (BIO-RAD) was used.
Serological detection of immune response to malaria 
antigens
Antibodies to P. falciparum and P. vivax Apical Mem-
brane Antigen-1 (AMA-1) and Merozoite Surface Pro-
tein-119 (MSP-119) were detected using plasma samples 
that were collected and stored in equal volume of 0.05% 
sodium azide by Enzyme Linked Immunosorbent Assay 
(ELISA), as previously described [29].
Data analysis
All analyses were performed with STATA 12 (StataCorp., 
TX, USA) and Graph Pad Prism 5.0 (Graph Pad Soft-
ware Inc., CA, USA). Asymptomatic malaria was defined 
as malaria infections that lack typical clinical symptoms 
(absence of fever at the time of sampling or absence of 
history of fever 48 h before sampling) but are detectable 
by microscopy, rapid diagnostic test or molecular meth-
ods [30]. Antibody prevalence was determined per anti-
gen after defining a cut-off optical density (OD) using 
the mixture model [31]. Prevalence was then used for 
the separate antigens and for the combined P. falciparum 
and the combined P. vivax antigens [17]. Chi square or 
Fisher’s Exact tests were used for dichotomous analyses; 
logistic or linear regression models were used for multi-
variate analyses. The correlation between continuous var-
iables was assessed by Spearman correlation coefficient; 
continuous variables were compared between groups 
using the non-parametric Wilcoxon Rank Sum test.
Results
Parasite and gametocyte prevalence by microscopy 
and qPCR
During the first cross-sectional survey (June 2015), 551 
students were enrolled from 5 elementary schools. The 
median age of the students was 12  years (IQR 11–14) 
(Table  1). During the second survey (November 2015), 
three of the five schools were revisited and 87.8% 
(294/335) students were successfully sampled for a sec-
ond time. Microscopy detected only 6 infections (3 in 
each survey), which were all from Jawi. There were seven 
febrile students (axillary temperature ≥37.5  °C) who 
were all RDT negative but 1 was positive for P. vivax by 
microscopy with 6267  parasites/μL. During the second 
survey, 14.6% (43/294) of the children reported that they 
had been treated for malaria in the time-period between 
the two surveys (Table 1).
Parasite prevalence by (DNA-based) qPCR during 
the first survey was 7.8% (43/551) for P. falciparum and 
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2.4% (13/551) for P. vivax (Table  2). During the second 
survey parasite prevalence was 12.9% (38/294) for P. fal-
ciparum and 4.8% (14/294) for P. vivax. Of all parasite-
positive individuals, 7.1% (4/56) and 5.4% (3/52) had 
mixed P. falciparum and P. vivax infections in the first 
and second survey, respectively. Nine individuals (29%, 
9/31) who were P. falciparum positive in the first survey 
and sampled again in the second survey were again P. fal-
ciparum positive; 28 (10.7%, 28/263) acquired a P. falci-
parum infection after being negative in the first survey. 
Two individuals (22%, 2/9) who were P. vivax positive in 
the first survey and sampled again in the second survey 
remained P. vivax positive; 12 (4.2%, 12/285) acquired a P. 
vivax infection.
Jawi, the study site at the lowest altitude (1218 metres 
above sea level), had the highest prevalence of Plasmo-
dium infections; 16.8% (18/107) and 25.0% (25/100) dur-
ing the first and second surveys, respectively (Fig.  2). 
While P. falciparum and P. vivax infections were detected 
in Andassa, Jawi, Yeboden and Yinessa, only P. falcipa-
rum infections were found in Ahuri (2010 metres above 
sea level), where the prevalence of P. falciparum infection 
was 9.9% (11/111) during the first and 8.2% (8/98) during 
the second survey.
Gametocyte carriage was tested for all qPCR para-
site positive and negative individuals. Of all samples 
from the first and second survey, 1.3% (7/551) and 2.0% 
(6/294) were P. falciparum gametocyte positive. Among 
P. falciparum qPCR positive individuals, P. falciparum 
gametocyte prevalence by (RNA-based) qRT-PCR was 
9.3% (4/43) in the first and 10.8% (4/37) in the second 
survey (Table 2). Of all samples from the first and second 
survey, 2.0% (11/551) and 4.1% (12/294) were P. vivax 
gametocyte positive. Among P. vivax qPCR positive 
individuals, P. vivax gametocyte prevalence was 69.2% 
(9/13) in the first and 57.1% (8/14) in the second survey 
(Table 2).
Parasite densities in relation to detectability by microscopy 
and gametocyte densities
Densities of P. falciparum and P. vivax infections were 
commonly low (Fig.  3). The 4 samples, that had micro-
scopically detectable P. falciparum parasites showed 
higher median parasite density by qPCR (median density 
326.1 parasites/μL; IQR 227.3–759.6,) compared to the 81 
samples that were microscopy negative (median density 
24.1  parasites/μL; IQR 17.7–32.4, p  =  0.001). Similarly, 
the two samples, that had microscopically detectable P. 
vivax parasites also had higher parasite density by qPCR 
(density 56.0 and 8627.4  parasites/μL) compared to 
the 26 samples that were microscopy negative (median 
density 15.6 parasites/μL; IQR 8.5–30.5, p = 0.03). Esti-
mated gametocyte densities were low for both P. falcipa-
rum (median 10.4  gametocytes/μL; IQR 3.1–51.2) and 
especially P. vivax (median 2.3  gametocytes/μL; IQR 
0.7–32.0). P. falciparum qRT-PCR gametocyte density 
was positively associated with P. falciparum qPCR para-
site density (Fig. 4; spearman correlation coefficient 0.83, 
Table 1 Demographic, clinical and malariometric characteristics of study participants
Ahuri Andassa Jawi Yeboden Yinesa Total
Characteristics
 Female sex, % (n/N) 52.3 (57/109) 49.6 (58/117) 48.1 (51/106) 50.9 (56/110) 42.5 (45/106) 48.7 (267/551)
 Age in years, median (25th–75th percentile) 13 (11–14) 12 (11–13) 12 (10–14) 12 (11–13) 12 (10–14) 12 (11–14)
Fever (temperature ≥37.5 °C)
 Survey 1, % (n/N) 0.9 (1/109) 1.7 (2/117) 0 2.8 (3/109) 0 1.1 (6/536)
 Survey 2, % (n/N) 0 0 1.1 (1/94) ND ND 0.3 (1/294)
Reported malaria between the two surveys
12.2 (12/98) 6.3 (6/96) 25.0 (25/100) ND ND 14.6 (43/294)
Table 2 Overview of submicroscopic Plasmodium parasites and gametocytes prevalence
Index First survey Second survey
P. falciparum P. vivax P. falciparum P. vivax
Overall parasite prevalence, % (n/N) 9.4 (52/551) 16.7 (49/294)
Parasite prevalence, % (n/N) 7.8 (43/551) 2.4 (13/551) 12.9 (38/294) 4.8 (14/294)
Overall gametocyte prevalence, % (n/N) 1.3 (7/551) 2.0 (11/551) 2.0 (6/294) 4.1 (12/294)
Gametocyte prevalence among parasite positive individuals, % (n/N) 9.3 (4/43) 69.2 (9/13) 10.5 (4/38) 57.1 (8/14)
Mixed species infections among parasite positive individuals, % (n/N) 7.1 (4/56) 5.8 (3/52)
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p = 0.010). Similarly, P. vivax qRT-PCR gametocyte den-
sity was positively associated with P. vivax qPCR para-
site density (Fig. 4; spearman correlation coefficient 0.58, 
p = 0.010). 
Seroprevalence and dynamics of antibody titres to malaria 
antigens
The prevalence of antibody responses to P. falciparum 
and P. vivax antigens was assessed as a more sensitive 
Fig. 2 Prevalence of submicroscopic P. falciparum and P. vivax malaria carriage by quantitative PCR. Prevalence of submicroscopic carriage of P. 
falciparum (gray bars), P. vivax (colorless bars) and mixed infections (hatched bars) among children from the five schools in the first survey and three 
schools from the second survey is presented. Error bars indicate the upper limit of the 95% confidence interval
Fig. 3 Parasite density of asymptomatic infections. Submicroscopic parasite densities as measured by 18S based qPCR for P. falciparum (a) and 
P. vivax (b) in microscopically positive (black circles) and only submicroscopic (colorless) asymptomatic malaria parasite carriers. Presented in the 
Y-axis is the Log10 transformed parasite density per µL of blood from the two surveys in school children from five schools (X-axis). The lines refer to 
the median parasite density from children in the specific school. Numbers below the figure indicate the qPCR parasite prevalence during the two 
surveys in the respective school. ND not determined
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indicator of malaria exposure than current parasite car-
riage by qPCR. Seroprevalence to P. falciparum and 
P. vivax AMA-1 and MSP-119 was strongly depend-
ent on site (Fig.  5). The prevalence of antibodies to P. 
falciparum AMA-1 and/or MSP-119 in the first survey 
was 11.0% (11/100) in Ahuri, 45.1% (41/91) in Andassa 
and 44.0% (44/100) in Jawi. In the second survey, 3.2% 
(3/95), 24.4% (22/90), and 34.7% (33/95) prevalence was 
detected, respectively. The prevalence of antibodies to 
P. vivax AMA-1 and/or MSP-119 in the first survey was 
9.0% (9/100) in Ahuri, 36.3% (33/91) in Andassa and 
27.0% (27/100) in Jawi. In the second survey, the preva-
lence of any P. vivax antibodies was 8.5% (8/94), 24.4% 
(22/90), and 26.3% (25/95), respectively. After adjustment 
Fig. 4 Association between parasite density and gametocyte density. The association between P. falciparum total parasite density versus gameto-
cyte density (a) and P. vivax total parasite density versus gametocyte density (b). P. falciparum qRT-PCR gametocyte density was positively associated 
with P. falciparum qPCR parasite density (Spearman correlation coefficient 0.83, p = 0.010). P. vivax qRT-PCR gametocyte density was positively 
associated with P. vivax qPCR parasite density (Spearman correlation coefficient 0.58, p = 0.010)
Fig. 5 Prevalence of antibodies generated to P. falciparum and P. vivax AMA-1 and MSP-119 in the study sites. The seroprevalence, positivity to 
antibodies generated against the P. falciparum AMA-1 (a) and MSP-119 (b), the P. vivax AMA-1 (d) and MSP-119 (e) during the first survey in June 2015 
(black bars) and the second survey in November 2015 (colorless bars). Any Pf (c) and Any Pv (d) refers to positivity to antibodies to either of the two P. 
falciparum (c) or P. vivax (d) antigens. The three schools that were surveyed for the two rounds are presented in the X axis
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for study site, the prevalence of antibodies against either 
P. falciparum antigen was strongly associated with age 
in both the first (odds ratio for each year increase in age 
1.29, 95% CI 1.14–1.46, p < 0.001) and second survey (OR 
1.50, 95% CI 1.26–1.79, p < 0.001). For P. vivax antibod-
ies, there was no statistically significant association with 
age (p ≥ 0.19). The prevalence and titer of P. falciparum 
antibodies was associated with parasite carriage by qPCR. 
Individuals who were parasite positive by qPCR in both 
surveys (n = 9) had a borderline significantly higher odds 
of being positive to either P. falciparum antigen in the 
second survey (OR 4.36, 95% CI 0.86–22.08, p = 0.076) 
compared to children who were parasite-negative in both 
surveys (n = 235), after adjustment for age and site. Indi-
viduals who were parasite positive in one but not both 
surveys (n = 50) had no significantly higher odds of being 
P. falciparum antibody positive in the second survey (OR 
1.03, 95% CI 0.44–2.45, p = 0.94) compared to children 
who were parasite-negative in both surveys, after adjust-
ment for age and site (Fig. 6). The titer of antibodies to P. 
falciparum AMA-1 (p < 0.001) and MSP-119 (p < 0.001) 
in the second survey was also higher in individuals who 
were parasite positive by qPCR in both surveys compared 
to those remaining parasite-free, after adjustment for 
age and study site (Fig. 6). Individuals who were parasite 
positive in one but not both surveys did not have statis-
tically significant higher antibody titers to P. falciparum 
MSP-119 (p =  0.35) or AMA-1 (p =  0.93) compared to 
individuals who remained parasite-free. No associations 
between qPCR parasite carriage and antibody responses 
to P. vivax antigens were observed (Fig. 6).
Gametocyte carriage is essential for onward transmis-
sion to mosquitoes and associated with total parasite bio-
mass [11]. At the end of follow-up (second survey), the 
prevalence of antibody responses to either of the P. falci-
parum antigens was 75.0% (9/12) for individuals who had 
P. falciparum gametocytes detected by qRT-PCR during 
the study period compared to 18.3% (49/268) for non-
carriers (p < 0.001). The prevalence of antibody responses 
to either of the P. vivax antigens was 31.3% (5/16) for 
Fig. 6 Dynamics of antibody responses. Antibody prevalence (top) and titre (bottom) for P. falciparum and P. vivax antigens in relation to qPCR 
detected parasite prevalence in neither of the surveys (parasite-free), in just one of the surveys (once positive) or in both surveys (twice positive). 
Antibody titre is presented for all individuals, including individuals whose ELISA optical density was below the threshold for positivity. The two 
individuals who were P. vivax positive in both surveys had optical density values for P. vivax AMA-1 and MSP-119 that were below the threshold for 
positivity and are therefore not presented in the antibody prevalence plot
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individuals who had P. vivax gametocytes detected by 
qRT-PCR during the study period compared to 19.0% 
(50/263) for non-carriers (p = 0.23).
Discussion
The current study adds to the available evidence on the 
wide-scale presence of submicroscopic parasitaemia. This 
study quantified submicroscopic parasites and concur-
rent gametocytes using highly sensitive molecular assays 
in asymptomatic schoolchildren. Whilst only 6 infections 
were detected by microscopy in 881 slides, 107 of 845 
blood samples were parasite positive by qPCR. A higher 
prevalence of malaria infections by molecular meth-
ods is commonly reported and the proportion of infec-
tions that is submicroscopic is highest in low-endemic 
settings [2, 3]. Nevertheless, the 18-fold higher parasite 
prevalence observed by qPCR compared to microscopy is 
remarkable [3]. Median densities were <10  parasites/μL 
for both P. falciparum and P. vivax, below the density of 
50–100 parasites/μL that is detectable by routine micros-
copy [32]. Expert microscopy may detect lower parasite 
densities but even expert microscopy may only have a 
sensitivity of ~29% for detecting parasite densities in the 
range of 1–10 parasites/μL [33].
The findings further demonstrated that approximately 
10% of all P. falciparum infections and 60% of all P. vivax 
infections had concurrent detectable low-density game-
tocytaemia [9, 11]. For both Plasmodium species game-
tocyte densities were positively associated with total 
parasite densities [11]. In P. falciparum gametocytes typi-
cally comprise <5% of the total parasite biomass. With 
the very low parasite densities that were detected in this 
study, it is conceivable that concurrent gametocyte den-
sities were too low to be detected by qRT-PCR. On the 
other hand, the finding that some individuals were game-
tocyte positive but negative for parasites by qPCR is likely 
to reflect the difference in sensitivity between DNA- and 
RNA-based assays [4] and illustrates that some infections 
could have been missed by qPCR [5]. This might partly 
explain infection of mosquitoes even when no parasites 
were detected by molecular methods [34]. Higher blood 
volume PCR [5] or more sensitive PCR targets [35] 
may reduce the proportion of false-negative PCR sam-
ples although it is likely that a fraction of infections will 
remain undetected with currently available diagnostics 
[5].
The current study identified heterogeneous transmis-
sion of Plasmodium species in the five study sites. At four 
sites both P. falciparum and P. vivax were prevalent; the 
former was the dominant species. In one highland site, 
Ahuri at 2010 metres above sea level, only P. falciparum 
infections were detected. Although parasite prevalence 
by qPCR was relatively low in Ahuri, it remains to be 
demonstrated whether infections were acquired locally. 
The finding may reflect a shift in altitude in P. falcipa-
rum distribution. In warmer years, an increase in the 
altitude at which malaria is observed has been reported 
for Ethiopia and Colombia [36]. The current findings may 
also be influenced by climatic changes, including the El 
Ǹino phenomenon that occurred during the study year 
and resulted in intermittent rain and increased tempera-
ture across the region. Intriguingly, antibodies to P. vivax 
AMA-1 and MSP-119 were detected in approximately 
9% of children in Ahuri. This may reflect past exposure 
to P. vivax [31], exposure outside the area of residence, 
P. vivax exposure that is too infrequent to be detected in 
parasitological surveys [17], or cross-reactivity of anti-
bodies acquired following P. falciparum exposure. For 
P. falciparum, antibody responses were associated with 
P. falciparum infections measured by qPCR. Individuals 
who were parasite positive in both surveys had higher 
prevalence and density of P. falciparum antibodies [37]. 
It is unclear whether this reflects boosting of antibody 
responses by circulating low densities of parasite antigens 
[38] or the fact that current infections are strongly asso-
ciated with cumulative past malaria exposure [39]. Para-
site prevalence and the incidence of new infections in 
the study populations was too low for meaningful assess-
ments of serological markers of malaria exposure as reli-
able indicator of recent malaria exposure or explore the 
longevity of antibody responses in relation to time since 
last infection. However, the current findings of an asso-
ciation between antibody prevalence and qPCR-detected 
infections and qRT-PCR detected gametocyte carriage, 
suggest that serological markers might be useful to iden-
tify P. falciparum exposed individuals or populations 
whose infections are undetectable by microscopy but 
may contribute to onward transmission. It is currently 
unclear why this association was not observed for P. 
vivax and more detailed longitudinal studies are required 
to robustly demonstrate the ability of serological markers 
of malaria exposure to detect (recent or current) malaria 
infections. Recently described serological markers of 
recent malaria infection [40] have the potential to per-
form considerably better in this respect since antibodies 
to AMA-1 and MSP-119 have a long half-life [29] and may 
be less informative to indicate ongoing malaria transmis-
sion in settings where transmission has declined. The 
age-range of the current study population was too nar-
row to generate a full age-seroprevalence curve that may 
demonstrate whether recent changes in malaria exposure 
have occurred [31, 41]. The association between antibody 
responses to P. falciparum blood stage antigens and P. fal-
ciparum gametocyte carriage is plausibly a consequence 
of a larger total parasite biomass in gametocyte carriers 
[11] that forms a stimulus for antibody production.
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The relevance of the low-density parasite reservoir 
that was described in the current study remains to be 
established. Whilst chronic low-density infections may 
have clinical consequences [6], most attention goes to 
their possible role in the human infectious reservoir for 
malaria [10, 13]. The current study demonstrates that a 
proportion of the low-density infections had detectable 
gametocyte densities. For P. falciparum this proportion 
was only 10% which is lower than commonly reported 
in parasite carriers detected in cross-sectional or clini-
cal surveys [9]. It may be argued that these infections 
may produce detectable gametocytes at a later stage, but 
the dynamics of gametocyte production and infectivity 
of submicroscopic infections is currently unknown. By 
comparison, the prevalence of gametocytes in P. vivax 
infections was higher, as has been described before, and 
may reflect the more rapid production and maturation 
of P. vivax gametocytes [9, 11, 42]. Efforts are currently 
ongoing to establish mosquito feeding facilities in the 
study area to determine the contribution of symptomatic, 
asymptomatic and submicroscopic infections to onward 
transmission to mosquitoes.
Conclusions
The current findings demonstrate a considerable pool 
of low density infections in schoolchildren in five low 
endemic sites in Ethiopia that are potentially to be 
included in malaria elimination initiatives by the Ethio-
pian Ministry of Health. Serological markers may play a 
role in identifying individuals or populations who are dis-
proportionately exposed to malaria and may be preferen-
tially targeted with interventions.
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